Literature DB >> 32486469

COVID-19 Related Coagulopathy: A Distinct Entity?

Benjamin Marchandot1, Laurent Sattler2, Laurence Jesel1,3, Kensuke Matsushita1,3, Valerie Schini-Kerth3, Lelia Grunebaum2, Olivier Morel1,3.   

Abstract

The coronavirus disease 2019 (COVID-19) pandemic has impacted healthcare communities across the globe on an unprecedented scale. Patients have had diverse clinical outcomes, but those developing COVID-19-related coagulopathy have shown a disproportionately worse outcome. This narrative review summarizes current evidence regarding the epidemiology, clinical features, known and presumed pathophysiology-based models, and treatment guidance regarding COVID-19 coagulopathy.

Entities:  

Keywords:  COVID-19; antiphospholipid antibodies; coronavirus disease 2019; endothelium; hemostasis; microparticles; thrombosis

Year:  2020        PMID: 32486469     DOI: 10.3390/jcm9061651

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  24 in total

Review 1.  COVID-19 associated thromboinflammation of renal capillary: potential mechanisms and treatment.

Authors:  Xiaojing Chen; Chengyuan Yu; Haijiao Jing; Chunxu Wang; Xinyi Zhao; Jinming Zhang; Shuoqi Zhang; Huan Liu; Rujuan Xie; Jialan Shi
Journal:  Am J Transl Res       Date:  2020-12-15       Impact factor: 4.060

Review 2.  Thrombosis, an important piece in the COVID-19 puzzle: From pathophysiology to therapy.

Authors:  Elena Bobescu; Luigi Geo Marceanu; Alexandru Covaciu; Larisa Alexandra Vladau
Journal:  Anatol J Cardiol       Date:  2021-09       Impact factor: 1.596

Review 3.  COVID-19 Sepsis: Pathogenesis and Endothelial Molecular Mechanisms Based on "Two-Path Unifying Theory" of Hemostasis and Endotheliopathy-Associated Vascular Microthrombotic Disease, and Proposed Therapeutic Approach with Antimicrothrombotic Therapy.

Authors:  Jae C Chang
Journal:  Vasc Health Risk Manag       Date:  2021-06-01

Review 4.  Entangling COVID-19 associated thrombosis into a secondary antiphospholipid antibody syndrome: Diagnostic and therapeutic perspectives (Review).

Authors:  Eugenio Cavalli; Alessia Bramanti; Rosella Ciurleo; Andrey I Tchorbanov; Antonio Giordano; Paolo Fagone; Cristina Belizna; Placido Bramanti; Yehuda Shoenfeld; Ferdinando Nicoletti
Journal:  Int J Mol Med       Date:  2020-06-25       Impact factor: 4.101

Review 5.  Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies.

Authors:  Hai Deng; Ting-Xuan Tang; Deng Chen; Liang-Sheng Tang; Xiang-Ping Yang; Zhao-Hui Tang
Journal:  Pathogens       Date:  2021-05-11

6.  Acute Pulmonary Embolism in Patients with and without COVID-19.

Authors:  Antonin Trimaille; Anaïs Curtiaud; Kensuke Matsushita; Benjamin Marchandot; Jean-Jacques Von Hunolstein; Chisato Sato; Ian Leonard-Lorant; Laurent Sattler; Lelia Grunebaum; Mickaël Ohana; Patrick Ohlmann; Laurence Jesel; Olivier Morel
Journal:  J Clin Med       Date:  2021-05-11       Impact factor: 4.241

7.  Thromboprophylaxis in COVID-19 - Rationale and considerations.

Authors:  Sotirios Bristogiannis; Dawn Swan; Jecko Thachil
Journal:  Adv Biol Regul       Date:  2021-07-23

Review 8.  Neurological Involvement in COVID-19 and Potential Mechanisms: A Review.

Authors:  Ghazal Aghagoli; Benjamin Gallo Marin; Nicole J Katchur; Franz Chaves-Sell; Wael F Asaad; Sarah A Murphy
Journal:  Neurocrit Care       Date:  2021-06       Impact factor: 3.532

9.  COVID-19-related intracranial imaging findings: a large single-centre experience.

Authors:  V Sawlani; S Scotton; K Nader; J P Jen; M Patel; K Gokani; P Denno; M Thaller; C Englezou; U Janjua; M Bowen; C Hoskote; T Veenith; G Hassan-Smith; S Jacob
Journal:  Clin Radiol       Date:  2020-09-15       Impact factor: 2.350

Review 10.  Thromboprophylaxis: balancing evidence and experience during the COVID-19 pandemic.

Authors:  Benjamin Marchandot; Antonin Trimaille; Anais Curtiaud; Kensuke Matsushita; Laurence Jesel; Olivier Morel
Journal:  J Thromb Thrombolysis       Date:  2020-11       Impact factor: 5.221

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.